{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:40:03Z","timestamp":1792176003946,"version":"4.4.0"},"reference-count":159,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017583","name":"Soci\u00e9t\u00e9 Fran\u00e7aise de Medecine physique et de R\u00e9adaptation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017583","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.euf.2020.02.007","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T02:14:24Z","timestamp":1584411264000},"page":"922-934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Nocturia and Nocturnal Polyuria in Neurological Patients: From Epidemiology to Treatment. A Systematic Review of the Literature"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1528-5569","authenticated-orcid":false,"given":"Rebecca","family":"Haddad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Denys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1224-9423","authenticated-orcid":false,"given":"Salvador","family":"Arlandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Giannantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Del Popolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5190-3259","authenticated-orcid":false,"given":"Jalesh N.","family":"Panicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"De Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2222-5070","authenticated-orcid":false,"given":"Kim","family":"Pauwaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp E.","family":"Van Kerrebroeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Everaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2020.02.007_bib0005","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","article-title":"Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"16","author":"GBD 2015 Neurological Disorders Collaborator Group","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.euf.2020.02.007_bib0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/nau.23917","article-title":"International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function","volume":"38","author":"Hashim","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0015","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13091","article-title":"Nocturia is more bothersome than daytime LUTS: results from an observational, real-life practice database including 8659 European and American LUTS patients","volume":"72","author":"Everaert","year":"2018","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.euf.2020.02.007_bib0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000353274","article-title":"Systematic review of the epidemiology of urinary incontinence and detrusor overactivity among patients with neurogenic overactive bladder","volume":"41","author":"Ruffion","year":"2013","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.euf.2020.02.007_bib0025","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.juro.2011.05.083","article-title":"Excessive nocturnal urine production is a major contributing factor to the etiology of nocturia","volume":"186","author":"Weiss","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.02.007_bib0030","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1002\/nau.23569","article-title":"How can we develop a more clinically useful and robust algorithm for diagnosing and treating nocturia? ICI-RS 2017","volume":"37","author":"Everaert","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0035","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/nau.23939","article-title":"International Continence Society consensus on the diagnosis and treatment of nocturia","volume":"38","author":"Everaert","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.euf.2020.02.007_bib0045","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2020.02.007_bib0050","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2020.02.007_bib0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","article-title":"Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity","volume":"66","author":"Kim","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.euf.2020.02.007_bib0060","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s11136-017-1765-4","article-title":"COSMIN Risk of Bias checklist for systematic reviews of patient-reported outcome measures","volume":"27","author":"Mokkink","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.euf.2020.02.007_bib0065","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.euf.2020.02.007_bib0070","unstructured":"CEBM. CEBM-Levels-of-Evidence-2.1.pdf."},{"key":"10.1016\/j.euf.2020.02.007_bib0075","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/JNN.0b013e3182a3cf67","article-title":"Lower urinary tract symptoms in men with Parkinson disease","volume":"45","author":"Robinson","year":"2013","journal-title":"J Neurosci Nurs"},{"key":"10.1016\/j.euf.2020.02.007_bib0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/nau.20193","article-title":"Prevalence of bladder dysfunction in Parkinson\u2019s disease","volume":"25","author":"Winge","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0085","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0b013e31827deb74","article-title":"The spectrum of nonmotor symptoms in early Parkinson disease","volume":"80","author":"Khoo","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.euf.2020.02.007_bib0090","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/mds.20844","article-title":"International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson\u2019s disease: the NMSQuest study","volume":"21","author":"Chaudhuri","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0095","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.parkreldis.2007.09.002","article-title":"Nonmotor symptoms of Parkinson\u2019s disease: prevalence and awareness of patients and families","volume":"14","author":"Cheon","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0100","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/mds.23394","article-title":"What are the most important nonmotor symptoms in patients with Parkinson\u2019s disease and are we missing them?","volume":"25","author":"Gallagher","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0105","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1590\/0004-282X20130005","article-title":"Frequency of non-motor symptoms in Peruvian patients with Parkinson\u2019s disease","volume":"71","author":"Cosentino","year":"2013","journal-title":"Arq Neuro-Psiquiatr"},{"key":"10.1016\/j.euf.2020.02.007_bib0110","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.clineuro.2012.07.032","article-title":"Prevalence of non motor features in a cohort of Parkinson\u2019s disease patients","volume":"115","author":"Khedr","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.euf.2020.02.007_bib0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00415-012-6600-9","article-title":"Prevalence of non-motor symptoms in young-onset versus late-onset Parkinson\u2019s disease","volume":"260","author":"Spica","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.euf.2020.02.007_bib0120","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.clineuro.2013.07.027","article-title":"The association between non-motor symptoms in Parkinson\u2019s disease and age at onset","volume":"115","author":"Zhou","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.euf.2020.02.007_bib0125","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jocn.2013.07.015","article-title":"Non-motor symptoms in Chinese Parkinson\u2019s disease patients","volume":"21","author":"Gan","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.euf.2020.02.007_bib0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s13760-014-0408-6","article-title":"A comparison between rate of nonmotor symptom development in essential tremor and Parkinson\u2019s disease","volume":"115","author":"Sengul","year":"2015","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.euf.2020.02.007_bib0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jns.2015.12.016","article-title":"Comparison of motor and non-motor features between essential tremor and tremor dominant Parkinson\u2019s disease","volume":"361","author":"Kwon","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.euf.2020.02.007_bib0140","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jns.2015.11.047","article-title":"Progression of non-motor symptoms in Parkinson\u2019s disease among different age populations: a two-year follow-up study","volume":"360","author":"Ou","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.euf.2020.02.007_bib0145","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019172","article-title":"Frequency of non-motor symptoms in Parkinson\u2019s disease presenting to tertiary care centre in Pakistan: an observational, cross-sectional study","volume":"8","author":"Mukhtar","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.euf.2020.02.007_bib0150","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00415-011-6392-3","article-title":"Gender-related differences in the burden of non-motor symptoms in Parkinson\u2019s disease","volume":"259","author":"Martinez-Martin","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.euf.2020.02.007_bib0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jns.2012.07.026","article-title":"Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson\u2019s disease","volume":"323","author":"Solla","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.euf.2020.02.007_bib0160","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.parkreldis.2013.06.009","article-title":"Gender and onset age-related features of non-motor symptoms of patients with Parkinson\u2019s disease\u2014a study from Southwest China","volume":"19","author":"Guo","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0165","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/jgs.12458","article-title":"Nonmotor symptoms in nursing home residents with Parkinson\u2019s disease: prevalence and effect on quality of life","volume":"61","author":"Weerkamp","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.euf.2020.02.007_bib0170","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1590\/S0004-282X2003000300007","article-title":"Urinary symptoms in Parkinson\u2019s disease: prevalence and associated factors","volume":"61","author":"Campos-Sousa","year":"2003","journal-title":"Arq Neuro-Psiquiatr"},{"key":"10.1016\/j.euf.2020.02.007_bib0175","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/nau.20983","article-title":"Idiopathic Parkinson\u2019s disease patients at the urologic clinic","volume":"30","author":"Ragab","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0180","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/nau.20681","article-title":"Voiding dysfunction in patients with Parkinson\u2019s disease: impact of neurological impairment and clinical parameters","volume":"28","author":"Sammour","year":"2009","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0185","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0190","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s13760-015-0478-0","article-title":"Effects of various factors on sleep disorders and quality of life in Parkinson\u2019s disease","volume":"115","author":"Telarovic","year":"2015","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.euf.2020.02.007_bib0195","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/jnnp.2011.241075","article-title":"Urinary dysfunction in early and untreated Parkinson\u2019s disease","volume":"82","author":"Uchiyama","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.euf.2020.02.007_bib0200","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1179\/1743132815Y.0000000010","article-title":"Association between nocturia and anxiety in Parkinson\u2019s disease","volume":"37","author":"Rana","year":"2015","journal-title":"Neurol Res"},{"key":"10.1016\/j.euf.2020.02.007_bib0205","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1179\/1743132813Y.0000000264","article-title":"Prevalence of nocturia in Parkinson\u2019s disease patients from various ethnicities","volume":"36","author":"Rana","year":"2014","journal-title":"Neurol Res"},{"key":"10.1016\/j.euf.2020.02.007_bib0210","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.4103\/0366-6999.168049","article-title":"Investigation of urination disorder in Parkinson\u2019s disease","volume":"128","author":"Zhang","year":"2015","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.euf.2020.02.007_bib0215","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1566-0702(01)00295-8","article-title":"Questionnaire-based assessment of pelvic organ dysfunction in Parkinson\u2019s disease","volume":"92","author":"Sakakibara","year":"2001","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.euf.2020.02.007_bib0220","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/ene.13290","article-title":"The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson\u2019s disease","volume":"24","author":"Picillo","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.euf.2020.02.007_bib0225","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.juro.2016.10.112","article-title":"Nocturnal urinary disorders and multiple sclerosis: clinical and urodynamic study of 309 patients","volume":"197","author":"Mauruc","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.02.007_bib0230","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1177\/1352458516663854","article-title":"Fatigue and fluid hydration status in multiple sclerosis: a hypothesis","volume":"22","author":"Cincotta","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.euf.2020.02.007_bib0235","doi-asserted-by":"crossref","first-page":"e713","DOI":"10.6061\/clinics\/2019\/e713","article-title":"Lower urinary tract symptoms and sexual dysfunction in men with multiple sclerosis","volume":"74","author":"Tom\u00e9","year":"2019","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.euf.2020.02.007_bib0240","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1179\/2045772315Y.0000000021","article-title":"Overactive bladder symptoms in patients with multiple sclerosis: frequency, severity, diagnosis and treatment","volume":"39","author":"Akko\u00e7","year":"2016","journal-title":"J Spinal Cord Med"},{"key":"10.1016\/j.euf.2020.02.007_bib0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1682\/JRRD.2009.08.0132","article-title":"Quality of life in patients with multiple sclerosis and urinary disorders: reliability and validity of Turkish-language version of Incontinence Quality of Life Scale","volume":"47","author":"Eyigor","year":"2010","journal-title":"J Rehabil Res Dev"},{"key":"10.1016\/j.euf.2020.02.007_bib0250","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0090-4295(00)01070-0","article-title":"Urodynamic pattern changes in multiple sclerosis","volume":"57","author":"Ciancio","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.euf.2020.02.007_bib0255","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.juro.2009.12.029","article-title":"Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS Patient Registry","volume":"183","author":"Mahajan","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.02.007_bib0260","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/01.STR.31.4.886","article-title":"Prevalence and impact of urinary symptoms among community-dwelling stroke survivors","volume":"31","author":"Brittain","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.euf.2020.02.007_bib0265","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/ageing\/afs009","article-title":"Urinary symptoms and natural history of urinary continence after first-ever stroke\u2014a longitudinal population-based study","volume":"41","author":"Williams","year":"2012","journal-title":"Age Ageing"},{"key":"10.1016\/j.euf.2020.02.007_bib0270","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/nau.22336","article-title":"Burden of overactive bladder symptom on quality of life in stroke patients","volume":"32","author":"Itoh","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0275","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/nau.20605","article-title":"Prevalence of lower urinary tract symptoms (LUTS) in stroke patients: a cross-sectional, clinical survey","volume":"27","author":"Tibaek","year":"2008","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0280","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/1557988317690283","article-title":"Lower urinary tract symptoms, erectile dysfunction, and quality of life in poststroke men: a controlled cross-sectional study","volume":"11","author":"Tibaek","year":"2017","journal-title":"Am J Mens Health"},{"key":"10.1016\/j.euf.2020.02.007_bib0285","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/luts.12078","article-title":"Survey and risk factors for lower urinary tract storage symptoms in middle-aged and older stroke patients in urban China","volume":"8","author":"Tian","year":"2016","journal-title":"Low Urin Tract Symptoms"},{"key":"10.1016\/j.euf.2020.02.007_bib0290","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/10749357.2018.1555389","article-title":"Post-stroke lower urinary system dysfunction and its relation with functional and mental status: a multicenter cross-sectional study","volume":"26","author":"Akko\u00e7","year":"2019","journal-title":"Top Stroke Rehabil"},{"key":"10.1016\/j.euf.2020.02.007_bib0295","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sc.2014.192","article-title":"A retrospective review of the ambulatory blood pressure patterns and diurnal urine production in subgroups of spinal cord injured patients","volume":"53","author":"Goh","year":"2015","journal-title":"Spinal Cord"},{"key":"10.1016\/j.euf.2020.02.007_bib0300","doi-asserted-by":"crossref","first-page":"40","DOI":"10.23736\/S1973-9087.17.04851-1","article-title":"Evaluation of the occurrence and diagnose definitions for nocturnal polyuria in spinal cord injured patients during rehabilitation","volume":"55","author":"Viaene","year":"2019","journal-title":"Eur J Phys Rehabil Med"},{"key":"10.1016\/j.euf.2020.02.007_bib0305","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/mds.23476","article-title":"Parkinson\u2019s disease sleep scale\u2014validation of the revised version PDSS-2","volume":"26","author":"Trenkwalder","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0310","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.parkreldis.2011.08.013","article-title":"Validation of the non-motor symptoms questionnaire (NMS-Quest)","volume":"18","author":"Rios Romenets","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0315","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/mds.21596","article-title":"The metric properties of a novel non-motor symptoms scale for Parkinson\u2019s disease: results from an international pilot study","volume":"22","author":"Chaudhuri","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0320","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1468-1331.2009.02788.x","article-title":"Longitudinal Parkinson\u2019s Disease Patient Study, Estudio Longitudinal de Pacients con Enfermedad da Parkinson Group. Independent validation of the scales for outcomes in Parkinson\u2019s disease-autonomic (SCOPA-AUT)","volume":"17","author":"Rodriguez-Blazquez","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.euf.2020.02.007_bib0325","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jns.2013.09.009","article-title":"A neurodegenerative disease sleep questionnaire: principal components analysis in Parkinson\u2019s disease","volume":"336","author":"Scullin","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.euf.2020.02.007_bib0330","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1007\/s00415-009-5141-3","article-title":"Parkinson\u2019s disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in Parkinsonian patients","volume":"256","author":"Perez-Lloret","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.euf.2020.02.007_bib0335","first-page":"30","article-title":"Test-retest reliability of the Urge-Urinary Distress Inventory and Female Sexual Function Index in women with multiple sclerosis","volume":"28","author":"Borello-France","year":"2008","journal-title":"Urol Nurs"},{"key":"10.1016\/j.euf.2020.02.007_bib0340","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.juro.2014.01.027","article-title":"The validity and reliability of the neurogenic bladder symptom score","volume":"192","author":"Welk","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.02.007_bib0345","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/nau.20223","article-title":"The Danish Prostatic Symptom Score (DAN-PSS-1) questionnaire is reliable in stroke patients","volume":"25","author":"Tibaek","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0350","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1600-0404.2009.01279.x","article-title":"Validity of the Danish Prostate Symptom Score questionnaire in stroke","volume":"120","author":"Tibaek","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.euf.2020.02.007_bib0355","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12883-018-1092-6","article-title":"Brain MRI morphometric analysis in Parkinson\u2019s disease patients with sleep disturbances","volume":"18","author":"Radziunas","year":"2018","journal-title":"BMC Neurol"},{"key":"10.1016\/j.euf.2020.02.007_bib0360","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/nau.22953","article-title":"The impact of Pontine disease on lower urinary tract symptoms in patients with multiple sclerosis","volume":"36","author":"Weissbart","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0365","first-page":"127","article-title":"Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategies","volume":"5","author":"Stoffel","year":"2016","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.euf.2020.02.007_bib0370","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.juro.2018.04.068","article-title":"Does post-void residual volume predict worsening urological symptoms in patients with multiple sclerosis?","volume":"200","author":"Dray","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.02.007_bib0375","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5213\/inj.1938086.043","article-title":"Urodynamic mechanisms underlying overactive bladder symptoms in patients with Parkinson disease","volume":"23","author":"Vurture","year":"2019","journal-title":"Int Neurourol J"},{"key":"10.1016\/j.euf.2020.02.007_bib0380","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11884-015-0331-6","article-title":"Neurogenic causes of detrusor underactivity","volume":"10","author":"Kadow","year":"2015","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"10.1016\/j.euf.2020.02.007_bib0385","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0022-5347(01)66614-X","article-title":"The role of urodynamics in the evaluation of voiding dysfunction in men after cerebrovascular accident","volume":"155","author":"Nitti","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.02.007_bib0390","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11934-012-0269-6","article-title":"The incidence and etiology of overactive bladder in patients after cerebrovascular accident","volume":"13","author":"McKenzie","year":"2012","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.euf.2020.02.007_bib0395","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.parkreldis.2014.04.023","article-title":"Gender differences in non-motor symptoms in early Parkinson\u2019s disease: a 2-years follow-up study on previously untreated patients","volume":"20","author":"Picillo","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0400","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/bju.13613","article-title":"Prostate size, nocturia and the digital rectal examination: a cohort study of 30 500 men","volume":"119","author":"Stone","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2020.02.007_bib0405","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.juro.2016.08.001","article-title":"Circadian rhythms in water and solute handling in adults with a spinal cord injury","volume":"197","author":"Denys","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.02.007_bib0410","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/mdc3.12279","article-title":"Nocturia in patients with Parkinson\u2019s disease","volume":"3","author":"Smith","year":"2016","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.euf.2020.02.007_bib0415","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.purol.2015.02.004","article-title":"Is nocturnal polyuria more frequent among patients with Parkinson\u2019s disease?","volume":"25","author":"Romain","year":"2015","journal-title":"Prog Urol"},{"key":"10.1016\/j.euf.2020.02.007_bib0420","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2169\/internalmedicine.44.281","article-title":"Nocturnal polyuria with abnormal circadian rhythm of plasma arginine vasopressin in post-stroke patients","volume":"44","author":"Sakakibara","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.euf.2020.02.007_bib0425","article-title":"The effects of sleep-disordered breathing symptoms on voiding patterns in stroke patients","volume":"27","author":"Hardin-Fanning","year":"2007","journal-title":"Urol Nurs"},{"key":"10.1016\/j.euf.2020.02.007_bib0430","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00415-010-5705-2","article-title":"Nocturia is an independent predictor of severe obstructive sleep apnea in patients with ischemic stroke","volume":"258","author":"Chen","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.euf.2020.02.007_bib0435","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/nau.22365","article-title":"Nocturia and overnight polysomnography in Parkinson disease","volume":"32","author":"Vaughan","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0440","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.sleep.2009.05.008","article-title":"Is obstructive sleep apnea a problem in Parkinson\u2019s disease?","volume":"11","author":"Cochen De Cock","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.euf.2020.02.007_bib0445","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jns.2014.08.025","article-title":"Parasomnias and isolated sleep symptoms in Parkinson\u2019s disease: a questionnaire study on 661 patients","volume":"346","author":"Ylikoski","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.euf.2020.02.007_bib0450","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clineuro.2014.06.027","article-title":"Clinical features associated with sleep disturbances in Parkinson\u2019s disease","volume":"124","author":"Bj\u00f8rnar\u00e5","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.euf.2020.02.007_bib0455","doi-asserted-by":"crossref","first-page":"698","DOI":"10.23736\/S1973-9087.17.04886-9","article-title":"Spasticity or periodic limb movements?","volume":"54","author":"Levy","year":"2018","journal-title":"Eur J Phys Rehabil Med"},{"key":"10.1016\/j.euf.2020.02.007_bib0460","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/mdc3.12374","article-title":"Nocturia in Parkinson\u2019s disease: why does it occur and how to manage?","volume":"3","author":"Batla","year":"2016","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.euf.2020.02.007_bib0465","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000495797","article-title":"Autonomic symptoms correlate with non-autonomic non-motor symptoms and sleep problems in patients with Parkinson\u2019s disease","volume":"80","author":"Matsubara","year":"2018","journal-title":"Eur Neurol"},{"key":"10.1016\/j.euf.2020.02.007_bib0470","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sc.2016.100","article-title":"Diurnal blood pressure and urine production in acute spinal cord injury compared with controls","volume":"55","author":"Goh","year":"2017","journal-title":"Spinal Cord"},{"key":"10.1016\/j.euf.2020.02.007_bib0475","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41393-018-0081-3","article-title":"Comparison of diurnal blood pressure and urine production between people with and without chronic spinal cord injury","volume":"56","author":"Goh","year":"2018","journal-title":"Spinal Cord"},{"key":"10.1016\/j.euf.2020.02.007_bib0480","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1310\/sci1903-229","article-title":"Calorie and protein intake in acute rehabilitation inpatients with traumatic spinal cord injury versus other diagnoses","volume":"19","author":"Pellicane","year":"2013","journal-title":"Top Spinal Cord Inj Rehabil"},{"key":"10.1016\/j.euf.2020.02.007_bib0485","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jns.2013.03.022","article-title":"Disease duration-related differences in non-motor symptoms: a study of 616 Chinese Parkinson\u2019s disease patients","volume":"330","author":"Guo","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.euf.2020.02.007_bib0490","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00702-012-0928-2","article-title":"Nonmotor symptoms of Parkinson\u2019s disease: the patient\u2019s perspective","volume":"120","author":"Breen","year":"2013","journal-title":"J Neural Transm"},{"key":"10.1016\/j.euf.2020.02.007_bib0495","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2015.11.003","article-title":"How well do Parkinson\u2019s disease patients turn in bed? Quantitative analysis of nocturnal hypokinesia using multisite wearable inertial sensors","volume":"23","author":"Sringean","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0500","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.ju.0000103274.38694.b1","article-title":"Can higher doses of oxybutynin improve efficacy in neurogenic bladder?","volume":"171","author":"Bennett","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.02.007_bib0505","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0022-5347(17)45940-4","article-title":"Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia","volume":"135","author":"Gajewski","year":"1986","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.02.007_bib0510","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.parkreldis.2015.02.025","article-title":"Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson\u2019s disease","volume":"21","author":"Zesiewicz","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0515","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.parkreldis.2018.07.005","article-title":"Mirabegron in patients with Parkinson disease and overactive bladder symptoms: a retrospective cohort","volume":"57","author":"Peyronnet","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0520","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419843458","article-title":"Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson\u2019s disease: a pilot study","volume":"12","author":"Gubbiotti","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0525","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(95)90485-9","article-title":"Nabilone in the treatment of multiple sclerosis","volume":"345","author":"Martyn","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.euf.2020.02.007_bib0530","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1191\/1352458504ms1063oa","article-title":"An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis","volume":"10","author":"Brady","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.euf.2020.02.007_bib0535","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1177\/1352458510378020","article-title":"Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis","volume":"16","author":"Kavia","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.euf.2020.02.007_bib0540","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/sc.2008.172","article-title":"Clinical outcome of sacral neuromodulation in incomplete spinal cord injured patients suffering from neurogenic lower urinary tract symptoms","volume":"47","author":"Lombardi","year":"2009","journal-title":"Spinal Cord"},{"key":"10.1016\/j.euf.2020.02.007_bib0545","article-title":"Sacral nerve neuromodulation in patients with underlying neurologic disease","volume":"197","author":"Wallace","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.euf.2020.02.007_bib0550","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/nau.21009","article-title":"Sacral neuromodulation for treating neurogenic bladder dysfunction: clinical and urodynamic study","volume":"30","author":"Chaabane","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0555","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.juro.2011.04.071","article-title":"Botulinum toxin type A in patients with Parkinson\u2019s disease and refractory overactive bladder","volume":"186","author":"Giannantoni","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.02.007_bib0560","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.urology.2013.09.017","article-title":"OnabotulinumtoxinA office treatment for neurogenic bladder incontinence in Parkinson\u2019s disease","volume":"83","author":"Anderson","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.euf.2020.02.007_bib0565","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.juro.2009.06.023","article-title":"Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson\u2019s disease and multiple system atrophy","volume":"182","author":"Giannantoni","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.02.007_bib0570","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12894-016-0174-2","article-title":"Preserved micturition after intradetrusor onabotulinumtoxinA injection for treatment of neurogenic bladder dysfunction in Parkinson\u2019s disease","volume":"16","author":"Kn\u00fcpfer","year":"2016","journal-title":"BMC Urol"},{"key":"10.1016\/j.euf.2020.02.007_bib0575","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/nau.20153","article-title":"Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis","volume":"25","author":"Schulte-Baukloh","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0580","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21209","article-title":"Botulinum injections for the treatment of bladder symptoms of multiple sclerosis","volume":"62","author":"Kalsi","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.euf.2020.02.007_bib0585","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.juro.2010.05.035","article-title":"The effect of botulinum toxin type a on overactive bladder symptoms in patients with multiple sclerosis: a pilot study","volume":"184","author":"Mehnert","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.02.007_bib0590","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1464-4096.2001.02422.x","article-title":"Transcutaneous electrical nerve stimulation in the treatment of neurological patients with urinary symptoms","volume":"88","author":"Skeil","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2020.02.007_bib0595","article-title":"Interventions for treating urinary incontinence after stroke in adults","volume":"2","author":"Thomas","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.euf.2020.02.007_bib0600","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/WON.0000000000000078","article-title":"Transcutaneous tibial nerve stimulation in the treatment of lower urinary tract symptoms and its impact on health-related quality of life in patients with Parkinson disease: a randomized controlled trial","volume":"42","author":"Perissinotto","year":"2015","journal-title":"J Wound Ostomy Continence Nurs"},{"key":"10.1016\/j.euf.2020.02.007_bib0605","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/nau.20733","article-title":"The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction","volume":"28","author":"Kabay","year":"2009","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0610","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1177\/1352458511414040","article-title":"Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial","volume":"17","author":"Gobbi","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.euf.2020.02.007_bib0615","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.juro.2013.09.036","article-title":"Maintenance percutaneous posterior nerve stimulation for refractory lower urinary tract symptoms in patients with multiple sclerosis: an open label, multicenter, prospective study","volume":"191","author":"Zecca","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.02.007_bib0620","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/nau.22868","article-title":"Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results","volume":"36","author":"Canbaz Kabay","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0625","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.urology.2015.09.026","article-title":"The clinical and urodynamic results of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson\u2019s disease","volume":"87","author":"Kabay","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.euf.2020.02.007_bib0630","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/sj.sc.3100440","article-title":"Is there a place for pudendal nerve maximal electrical stimulation for the treatment of detrusor hyperreflexia in spinal cord injury patients?","volume":"36","author":"Pr\u00e9vinaire","year":"1998","journal-title":"Spinal Cord"},{"key":"10.1016\/j.euf.2020.02.007_bib0635","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/026921559701100304","article-title":"Pelvic floor rehabilitation is effective in patients with multiple sclerosis","volume":"11","author":"Vahtera","year":"1997","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.euf.2020.02.007_bib0640","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/nau.20941","article-title":"Pelvic floor muscle training in the treatment of lower urinary tract dysfunction in women with multiple sclerosis","volume":"29","author":"L\u00facio","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0645","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/WON.0000000000000223","article-title":"Pelvic floor muscle training with and without electrical stimulation in the treatment of lower urinary tract symptoms in women with multiple sclerosis","volume":"43","author":"L\u00facio","year":"2016","journal-title":"J Wound Ostomy Continence Nurs"},{"key":"10.1016\/j.euf.2020.02.007_bib0650","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/nau.20209","article-title":"Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study","volume":"25","author":"McClurg","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0655","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/WNL.0b013e318219fab3","article-title":"Behavioral therapy to treat urinary incontinence in Parkinson disease","volume":"76","author":"Vaughan","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.euf.2020.02.007_bib0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2005.00431.x","article-title":"Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis","volume":"112","author":"Bosma","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.euf.2020.02.007_bib0665","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/nau.23921","article-title":"Desmopressin for treating nocturia in patients with multiple sclerosis: a systematic review: a report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS)","volume":"38","author":"Ph\u00e9","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0670","first-page":"416","article-title":"Long term use of desmopressin for urinary symptoms in multiple sclerosis","volume":"5","author":"Tubridy","year":"1999","journal-title":"Mult Scler"},{"key":"10.1016\/j.euf.2020.02.007_bib0675","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jnnp.46.9.854","article-title":"The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis","volume":"46","author":"Hilton","year":"1983","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.euf.2020.02.007_bib0680","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11255-007-9232-8","article-title":"Maximal bladder capacity is a positive predictor of response to desmopressin treatment in patients with MS and nocturia","volume":"40","author":"Zahariou","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.euf.2020.02.007_bib0685","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/01952307.1994.11735930","article-title":"DDAVP in the urological management of the difficult neurogenic bladder in spinal cord injury: preliminary report","volume":"17","author":"Chancellor","year":"1994","journal-title":"J Am Paraplegia Soc"},{"key":"10.1016\/j.euf.2020.02.007_bib0690","first-page":"333","article-title":"The use of desmopressin in the management of nocturnal enuresis in patients with spinal cord injury","volume":"43","author":"Zahariou","year":"2007","journal-title":"Eura Medicophys"},{"key":"10.1016\/j.euf.2020.02.007_bib0695","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/mds.870100318","article-title":"Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson\u2019s disease","volume":"10","author":"Suchowersky","year":"1995","journal-title":"Mov Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0700","doi-asserted-by":"crossref","first-page":"E43","DOI":"10.1111\/bju.14672","article-title":"Conservative treatment for leg oedema and the effect on nocturnal polyuria in patients with spinal cord injury","volume":"123","author":"Viaene","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2020.02.007_bib0705","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190998","article-title":"Improvements in bladder, bowel and sexual outcomes following task-specific locomotor training in human spinal cord injury","volume":"13","author":"Hubscher","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.euf.2020.02.007_bib0710","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2147\/CIA.S193448","article-title":"Continuous positive airway pressure improves nocturnal polyuria in ischemic stroke patients with obstructive sleep apnea","volume":"14","author":"Yu","year":"2019","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.euf.2020.02.007_bib0715","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12883-018-1114-4","article-title":"Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)","volume":"18","author":"Drake","year":"2018","journal-title":"BMC Neurol"},{"key":"10.1016\/j.euf.2020.02.007_bib0720","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/mds.20874","article-title":"Sleep complaints and their relation with drug treatment in patients suffering from Parkinson\u2019s disease","volume":"21","author":"G\u00f3mez-Esteban","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0725","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.parkreldis.2003.08.001","article-title":"Effects of pergolide on nocturia in Parkinson\u2019s disease: three female cases selected from over 400 patients","volume":"10","author":"Kuno","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0730","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.23441","article-title":"Rotigotine effects on early morning motor function and sleep in Parkinson\u2019s disease: a double-blind, randomized, placebo-controlled study (RECOVER)","volume":"26","author":"Trenkwalder","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0735","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00702-010-0506-4","article-title":"Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson\u2019s disease","volume":"117","author":"Giladi","year":"2010","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.euf.2020.02.007_bib0740","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/00207454.2017.1387111","article-title":"The effects of transdermal rotigotine on non-motor symptoms of Parkinson\u2019s disease: a multicentre, observational, retrospective, post-marketing study","volume":"128","author":"Valldeoriola","year":"2018","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.euf.2020.02.007_bib0745","first-page":"15","article-title":"Efficacy of deep brain stimulation of the subthalamic nucleus on autonomic dysfunction in patients with Parkinson\u2019s disease","volume":"53","author":"Pietraszko","year":"2013","journal-title":"Folia Med Cracov"},{"key":"10.1016\/j.euf.2020.02.007_bib0750","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/nau.22237","article-title":"Bladder dysfunction in advanced Parkinson\u2019s disease","volume":"31","author":"Winge","year":"2012","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2020.02.007_bib0755","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.parkreldis.2011.05.009","article-title":"The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson\u2019s disease","volume":"17","author":"Nazzaro","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0760","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mds.10639","article-title":"Improvement of sleep quality in patients with advanced Parkinson\u2019s disease treated with deep brain stimulation of the subthalamic nucleus","volume":"19","author":"Hjort","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0765","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-0404.1999.tb00732.x","article-title":"Nocturnal subcutaneous apomorphine infusion in Parkinson\u2019s disease and restless legs syndrome","volume":"100","author":"Reuter","year":"1999","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.euf.2020.02.007_bib0770","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3233\/JPD-2011-11037","article-title":"Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson\u2019s disease compared to conventional therapy: a real life study of non motor effect","volume":"1","author":"Martinez-Martin","year":"2011","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.euf.2020.02.007_bib0775","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/WNF.0000000000000281","article-title":"Long-term outcome of adenosine A2A receptor antagonist on lower urinary tract symptoms in male Parkinson disease patients","volume":"41","author":"Kitta","year":"2018","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.euf.2020.02.007_bib0780","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1017\/cjn.2016.289","article-title":"Open-label study of sleep disturbances in patients with Parkinson\u2019s disease treated with rasagiline","volume":"43","author":"Panisset","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.euf.2020.02.007_bib0785","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/sj.sc.3100814","article-title":"Diurnal variation of antidiuretic hormone and urinary output in spinal cord injury","volume":"37","author":"Kilin\u00e7","year":"1999","journal-title":"Spinal Cord"},{"key":"10.1016\/j.euf.2020.02.007_bib0790","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/mds.22705","article-title":"Major nutritional issues in the management of Parkinson\u2019s disease","volume":"24","author":"Barichella","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.euf.2020.02.007_bib0795","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/bju.13774","article-title":"TANGO\u2014a screening tool to identify comorbidities on the causal pathway of nocturia","volume":"119","author":"Bower","year":"2017","journal-title":"BJU Int"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456920300638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456920300638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:51:20Z","timestamp":1762498280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456920300638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":159,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2405456920300638"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2020.02.007","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nocturia and Nocturnal Polyuria in Neurological Patients: From Epidemiology to Treatment. A Systematic Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2020.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}